TITLE

Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors

AUTHOR(S)
Farkouh, Michael
PUB. DATE
June 2010
SOURCE
ACP Journal Club;6/15/2010, Vol. 152 Issue 6, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on the clinical trial conducted on the use of the drug nateglinide in older adult patients with impaired glucose tolerance to reduce diabetes and cardiovascular disease (CV) risk factors. The trial studied 9518 patients of 50 years of age suffering from glucose intolerance. They were treated with nateglinide and lifestyle modification program. The results showed that nateglinide dis not reduced the risk of diabetes or CV diseases.
ACCESSION #
51696565

 

Related Articles

  • Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors. Farkouh, Michael // ACP Journal Club;6/15/2010, Vol. 152 Issue 6, p8 

    The article offers information on the clinical trial conducted on the use of the drug valsartan in adult patients with impaired glucose tolerance to reduce cardiovascular disease (CV) risk factors. The trial studied 9518 patients of 50 years of age suffering from glucose intolerance and CV...

  • Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Type 2 Diabetic Men. Kuusisto, Johanna; Mykkanen, Leena; Laakso, Markku; Lempiainen, Paivi // Diabetes Care;Sep2001, Vol. 24 Issue 9, p1629 

    Presents a study which investigated the clustering of cardiovascular risk factors in elderly men and women with type 2 diabetes. Research design and methods; Results; Conclusions.

  • The effect of different cardiovascular risk presentation formats of intentions, understanding and emotional affect: a randomised controlled trial using a web-based risk formatter (protocol). Waldron, Cherry-Ann; Gallacher, John; van der Weijden, Trudy; Newcombe, Robert; Elwyn, Glyn // BMC Medical Informatics & Decision Making;2010, Vol. 10 Issue 1, p41 

    Background: The future risk of heart disease can be predicted with increasing precision. However, more research is needed into how this risk is conveyed and presented. The aim of this study is to compare the effects of presenting cardiovascular risk in different formats on individuals' intention...

  • Risk Factors and Management of Gestational Diabetes. Chen, Penglong; Wang, Shuxiang; Ji, Jianying; Ge, Aiping; Chen, Chunlai; Zhu, Yanfei; Xie, Ni; Wang, Yi // Cell Biochemistry & Biophysics;Mar2015, Vol. 71 Issue 2, p689 

    Gestational diabetes mellitus (GDM) is considered to be a typical condition of glucose intolerance in which a woman previously undiagnosed with diabetes exhibits high levels of blood glucose during the third trimester of pregnancy. It can hence be defined as any degree of intolerance to glucose...

  • Diabetes Q&A.  // PT: Magazine of Physical Therapy;2001 Supplement, p14 

    The article offers information on diabetes, its causes and risk factors associated with it.

  • Diabetes prevention - the global hope on the horizon. Schwarz, Peter E. H. // Indian Journal of Medical Research;Nov2012, Vol. 136 Issue 5, p719 

    The author observes that researchers, physicians and politicians are intensively seeking solution for the fast growth worldwide of diabetes mellitus. He argues that the evidence that diabetes is a preventable disease is excellent as several randomized clinical trials have shown that more than 50...

  • Increasing efficacy of primary care-based counseling for diabetes prevention: Rationale and design of the ADAPT (Avoiding Diabetes Thru Action Plan Targeting) trial. Mann, Devin M.; Lin, Jenny J. // Implementation Science;2012, Vol. 7 Issue 1, p1 

    Background: Studies have shown that lifestyle behavior changes are most effective to prevent onset of diabetes in high-risk patients. Primary care providers are charged with encouraging behavior change among their patients at risk for diabetes, yet the practice environment and training in...

  • Type 2 Diabetes Prevention in the Real World. Absetz, Pilvikki; Oldenburg, Brian; Hankonen, Nelli; Valve, Raisa; Heinonen, Heikki; Nissinen, Aulikki; Fogelholm, Mikael; Talja, Martti; Uutela, Antti // Diabetes Care;Aug2009, Vol. 32 Issue 8, p1418 

    OBJECTIVE -- We study the effectiveness of the GOAL Lifestyle Implementation Trial at the 36-month follow-up. RESEARCH DESIGN AND METHODS -- Participants (n = 352, type 2 diabetes risk score FINDRISC = 16.2 ± 3.3, BMI 32.6 ± 5.0 kg/m²) received six lifestyle counseling sessions over 8...

  • At Last...Type 1 Diabetes Can Be Prevented (But Only in Rats)! Unger, Jeff // Internal Medicine Alert;1/15/2013, Vol. 35 Issue 1, p4 

    The author reviewed the strategies of predicting and preventing type 1 diabetes across the different stages of development of the disorder. Not only can risk for type 1 diabetes be predicted, but the approximate age of diabetes onset in children can be ascertained. Although diabetes can be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics